Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 2/2011

01-04-2011 | Correspondence

Rothia dentocariosa endocarditis with mitral valve prolapse: case report and brief review

Authors: S. Shakoor, N. Fasih, K. Jabeen, B. Jamil

Published in: Infection | Issue 2/2011

Login to get access

Excerpt

We present a case of endocarditis with a rare pathogen, Rothia dentocariosa, in a patient with mitral valve prolapse. The symptoms began 1 month after the patient underwent cholecystectomy. Endocarditis was successfully treated with outpatient parenteral therapy with ceftriaxone, and follow-up blood cultures remained negative. …
Literature
1.
Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically; approved standard—7th edn. CLSI document M7-A7. Wayne: Clinical Laboratory Standards Institute; 2006.
2.
Brown JM, Georg LK, Waters LC. Laboratory identification of Rothia dentocariosa and its occurrence in human clinical materials. Appl Environ Microbiol. 1969;17:150–6.
3.
Favero M, Raffeiner B, Cecchin D, Schiavon F. Septic arthritis caused by Rothia dentocariosa in a patient with rheumatoid arthritis receiving etanercept therapy. J Rheumatol. 2009;36:2846–7.PubMedCrossRef
4.
Schiff MJ, Kaplan MH. Rothia dentocariosa pneumonia in an immunocompromised patient. Lung. 1987;165:279–82.PubMedCrossRef
5.
Wiesmayr S, Stelzmueller I, Berger N, Jungraithmayr TC, Fille M, Eller M, et al. Rothia dentocariosa sepsis in a pediatric renal transplant recipient having post-transplant lymphoproliferative disorders. Pediatr Transplant. 2006;10:377–9.PubMedCrossRef
6.
Nivar-Aristy RA, Krajewski LP, Washington JA. Infection of an arteriovenous fistula with Rothia dentocariosa. J Infect. 1998;37:292–5.CrossRef
7.
Michon J, Jeulin D, Lang JM, Cattoir V. Rothia aeria acute bronchitis: the first reported case. Infection. 2010;38:335–7.PubMedCrossRef
8.
Boudewijns M, Magerman K, Verhaegen J, Debrock G, Peetermans WE, Donkersloot P, et al. Rothia dentocariosa endocarditis and mycotic aneurysms: case report and review of the literature. Clin Microbiol Infect. 2003;9:222–9.PubMedCrossRef
9.
Almuzara MN, Marinansky AL, Valenzuela VC, Vay CA. Endocarditis due to Rothia dentocariosa complicated by septic cerebral embolosim. Enferm Infec Microbiol Clin. 2004;22:255–6.CrossRef
10.
Sadhu A, Loewenstein R, Klotz SA. Rothia dentocariosa endocarditis complicated by multiple cerebellar hemorrhages. Diagn Microbiol Infect Dis. 2005;53:239–40.PubMedCrossRef
11.
Park SD, Uh Y, Lee HG, Jang IH, Yoon KJ, Namgoong MK. A case of bacteremia caused by Rothia dentocariosa. Korean J Clin Microbiol. 2009;12:133–7.
12.
Yang CY, Hsueh PR, Lu CY, Tsai HY, Lee PI, Shao PL, et al. Rothia dentocariosa bacteremia in children: report of two cases and review of the literature. J Formos Med Assoc. 2007;106:S33–8.PubMedCrossRef
13.
Salamon SA, Prag J. Three cases of Rothia dentocariosa bacteremia: frequency in Denmark and a review. Scand J Infect Dis. 2002;34:153–7.PubMedCrossRef
14.
Shin JH, Shim JD, Kim HR, Sinn JB, Kook JK, Lee JN. Rothia dentocariosa septicemia without endocarditis in a neonatal infant with meconium aspiration syndrome. J Clin Microbiol. 2004;42:4891–2.PubMedCrossRef
15.
16.
Sudduth EJ, Rozich JD, Farrar WE. Rothia dentocariosa endocarditis complicated by perivalvular abscess. Clin Infect Dis. 1993;17:772–5.PubMedCrossRef
17.
Binder D, Zbinden R, Widmer U, Opravil M, Krause M. Native and prosthetic valve endocarditis caused by Rothia dentocariosa: diagnostic and therapeutic considerations. Infection. 1997;25:22–6.PubMedCrossRef
18.
Ferraz V, McCarthy K, Smith D, Koornhof HJ. Rothia dentocariosa and aortic root abscess. J Infect. 1998;37:292–5.PubMedCrossRef
19.
Morris SK, Shudeshna N, Suh KN, Evans GA. Recurrent chronic ambulatory peritoneal dialysis-associated infection due to Rothia dentocariosa. Can J infect Dis Med Microbiol. 2004;15:171–3.PubMed
Metadata
Title
Rothia dentocariosa endocarditis with mitral valve prolapse: case report and brief review
Authors
S. Shakoor
N. Fasih
K. Jabeen
B. Jamil
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 2/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0087-7

Other articles of this Issue 2/2011

Infection 2/2011 Go to the issue

Clinical and Epidemiological Study

Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010

Case Report

A case of multifocal chronic Q fever osteomyelitis

Case Report

Acute cytomegalovirus pneumonia and hepatitis presenting during acute HIV retroviral syndrome

Images in Infection

Bullous cellulitis with Cryptococcus neoformans

Case Report

Osteomyelitis due to trimethoprim/sulfamethoxazole-resistant Edwardsiella tarda infection in a patient with X-linked chronic granulomatous disease

Clinical and Epidemiological Study

Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits